Can Neutrophil-to-Lymphocyte Ratio, Platelet Volume and Platelet Distribution Width Be Used as Indicators of Delirium?
Key facts
- Who runs it
- Ankara City Hospital Bilkent
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 221 people enrolled
- Started
- 14 Nov 2022
- Ended
- 14 Feb 2024
- Type of study
- Observational
- Record updated
- 22 November 2024
Who can take part
- Age
- 3 years to 9 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- ASA I-III risk group
- Planned to have adenoidectomy, tonsillectomy, and/or ventilation tube placement
Who cannot take part
- Children under 3 years old
- Children over 9 years old
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Postoperative delirium is a frequent complication in children undergoing general anesthesia. It has been suggested that inflammation and oxidative stress contribute to the pathophysiology of delirium. The aim of this prospective observational study was to investigate the relationship between inflammatory markers, and delirium. The main questions it aimed to answer were:
Read full original descriptionShow less
* Is there a realtionship between delirium and neutrophil-to-lymphocyte ratio? * Is there a realtionship between delirium and platelet volume? * Is there a realtionship between delirium and platelet distribution width? * What is the incidence of postoperative delirium in the study group?
The group in the trial
- Patients undergoing adenoidectomy, tonsillectomy and/or ventilation tube application
Patients undergoing adenoidectomy, tonsillectomy and/or ventilation tube application either premedicated or not, with ASA I-III risk group, followed up for 30 minutes postoperatively.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 22 November 2024